Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment
- PMID: 10419653
- DOI: 10.1006/cyto.1998.0457
Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment
Abstract
Interleukin 5 (IL-5), a cytokine with a range of activities on eosinophils, has been implicated in the allergic asthmatic reaction. We have investigated the kinetics of release of this cytokine into asthmatic airways as well as its relationship to eosinophil recruitment following allergen challenge. Twelve asthmatic patients underwent endobronchial allergen challenge and bronchoalveolar lavage (BAL) fluid was obtained either 4 h (n=6) or 24 h (n=6) after challenge. Four hours after challenge, levels of IL-5 were significantly increased in BAL fluid (10-fold concentration obtained from the allergen-challenge site compared with the saline control (median 2.67 pg/ml, range 1.0-7.4 pg/ml vs 1.0 pg/ml <1.0-2.4 pg/ml, P<0.05). At 24 h levels of IL-5 increased further at the allergen site but not at the saline control lavage (31.1 pg/ml, range 3.6-59. 0 pg/ml vs 1.5 pg/ml, range <1.5-4.9 pg/ml, respectively P<0.02). At 4h there was almost a three fold increase in IL-5 level, whereas at 24 h IL-5 levels were 20-fold greater. Differential cell counts showed that eosinophil numbers obtained 4 and 24 h after allergen challenge were 7 and 32 times higher than numbers after saline challenge. The parallel increase of eosinophil numbers and IL-5 concentrations in BAL fluid suggests that this cytokine may contribute to the eosinophil recruitment observed into asthmatic airways after allergen challenge.
Copyright 1999 Academic Press.
Similar articles
-
Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release.Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):469-76. doi: 10.1164/ajrccm.154.2.8756824. Am J Respir Crit Care Med. 1996. PMID: 8756824
-
Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.J Allergy Clin Immunol. 2000 Aug;106(2):293-301. doi: 10.1067/mai.2000.108112. J Allergy Clin Immunol. 2000. PMID: 10932073
-
Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways.J Immunol. 1996 Aug 15;157(4):1806-12. J Immunol. 1996. PMID: 8759771
-
Endobronchial allergen challenge.Eur Respir J Suppl. 1998 Mar;26:33S-35S. Eur Respir J Suppl. 1998. PMID: 9585878 Review.
-
The airway inflammatory response in allergic asthma and its relationship to clinical disease.Allergy. 1995;50(22 Suppl):13-21. doi: 10.1111/j.1398-9995.1995.tb02730.x. Allergy. 1995. PMID: 7793534 Review.
Cited by
-
Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.Toxicol Pathol. 2009 Feb;37(2):249-55. doi: 10.1177/0192623308329342. Epub 2009 Jan 29. Toxicol Pathol. 2009. PMID: 19181630 Free PMC article.
-
Activation states of blood eosinophils in asthma.Clin Exp Allergy. 2014 Apr;44(4):482-98. doi: 10.1111/cea.12292. Clin Exp Allergy. 2014. PMID: 24552191 Free PMC article. Review.
-
Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3.Apoptosis. 2016 Apr;21(4):421-31. doi: 10.1007/s10495-016-1226-5. Apoptosis. 2016. PMID: 26880402 Free PMC article.
-
Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future.Pharmaceuticals (Basel). 2023 Feb 10;16(2):270. doi: 10.3390/ph16020270. Pharmaceuticals (Basel). 2023. PMID: 37259416 Free PMC article. Review.
-
Integrin activation States and eosinophil recruitment in asthma.Front Pharmacol. 2013 Apr 1;4:33. doi: 10.3389/fphar.2013.00033. eCollection 2013. Front Pharmacol. 2013. PMID: 23554594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical